Showing results (461-470 of 539) with videos related to

Sort By:
Pageof 54
Annals of the Rheumatic Diseases|January 21, 2014
Validation of EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI)Raphaèle Seror, Elke Theander, Johan G Brun, et al.
Seminars in Arthritis and Rheumatism|November 14, 2018
Incidence and risk factors for adalimumab and infliximab anti-drug antibodies in rheumatoid arthritis: A European retrospective multicohort analysisJocelyn Quistrebert, Signe Hässler, Delphine Bachelet, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 17, 2015
Intravenous Immunoglobulin as an Immunomodulating Agent in Antineutrophil Cytoplasmic Antibody-Associated Vasculitides: A French Nationwide Study of Ninety-Two PatientsEtienne Crickx, Irène Machelart, Estibaliz Lazaro, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 10, 2023
Serum and Tissue Biomarkers Associated With Composite of Relevant Endpoints for Sjögren Syndrome (CRESS) and Sjögren Tool for Assessing Response (STAR) to B Cell-Targeted Therapy in the Trial of Anti-B Cell Therapy in Patients With Primary Sjögren Syndrome (TRACTISS)Elena Pontarini, Elisabetta Sciacca, Farzana Chowdhury, et al.
Seminars in Arthritis and Rheumatism|December 18, 2025
Juvenile-onset mixed connective tissue disease: A multicenter retrospective cohort studyKevin Chevalier, Brigitte Bader-Meunier, Isabelle Kone-Paut, et al.
Science Translational Medicine|July 26, 2013
NCR3/NKp30 contributes to pathogenesis in primary Sjogren's syndromeSylvie Rusakiewicz, Gaetane Nocturne, Thierry Lazure, et al.
Frontiers in Immunology|November 3, 2023
The purinergic receptor P2X7 and the NLRP3 inflammasome are druggable host factors required for SARS-CoV-2 infectionDéborah Lécuyer, Roberta Nardacci, Désirée Tannous, et al.
Arthritis and Rheumatism|May 28, 2010
Safety and efficacy of rituximab in systemic lupus erythematosus: results from 136 patients from the French AutoImmunity and Rituximab registryBenjamin Terrier, Zahir Amoura, Philippe Ravaud, et al.
RMD Open|October 23, 2025
Unravelling IPAF, VEDOSS and connective tissue diseases classifications through the mixed connective tissue disease spectrumKevin Chevalier, Benjamin Thoreau, Marc Michel, et al.
Annals of the Rheumatic Diseases|January 1, 2022
Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registryPedro M Machado, Saskia Lawson-Tovey, Anja Strangfeld, et al.
Pageof 54